Literature DB >> 21618166

Relevance and methods of interventional breast sonography in preoperative axillary lymph node staging.

I Gruber1, M Hahn, T Fehm, C Hann von Weyhern, A Stäbler, A Winckelmann, D Wallwiener, T Kühn.   

Abstract

Reduction of therapy-induced morbidity is an important goal for the improvement of the quality of breast cancer treatment. The introduction of sentinel lymph node biopsy (SLNB) significantly contributed to the reduction of surgery-induced morbidity in the shoulder-arm region. However, a clinically positive nodal status is still considered a contra-indication for SLNB. The current data constellation clearly shows that the clinical and also the sonographic malignancy assessment is insufficient for the accurate identification of the nodal status. A merely clinical and/or image-based appraisal of the axillary lymph node status would lead to overtreatment due to unnecessary axillary dissection in approximately 40 % of patients. In order to reduce the rate of unnecessary axillary dissection (AD), pretreatment interventional clarification is necessary to provide more detailed information about the histological condition of the lymph node. Comparing the currently available methods, fine needle aspiration (FNA) is the best in terms of cost and time requirement, practicability and complication rate. However, considering the sensitivity, it is inferior to ultrasound-guided core needle biopsy (CNB). Thus, a negative FNA outcome requires further clarification, which possibly can be performed with CNB. With a specificity of nearly 100 % and therefore a low rate of false positive cases for FNA, complete AD can be indicated by a positive FNA result. In the context of the interventional procedure, it must be stressed that FNA requires a high level of expertise on the part of both the examiner and the cytologist. The prerequisite for optimal interventional diagnostics of lymph nodes is an adequate sonographic assessment on the basis of standardized sonomorphological criteria. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21618166     DOI: 10.1055/s-0031-1273317

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  7 in total

1.  The role of combined assessment in preoperative axillary staging.

Authors:  Hazem Khout; Catherine Richardson; Hamid Toghyan; Tarannum Fasih
Journal:  Ochsner J       Date:  2013

2.  Sentinel Lymph Node Biopsy in Early Breast Cancer.

Authors:  Thorsten Kühn
Journal:  Breast Care (Basel)       Date:  2011-06-14       Impact factor: 2.860

3.  Sentinel Lymph Node Biopsy in T3 and T4b Breast Cancer Patients: Analysis in a Tertiary Cancer Hospital and Systematic Literature Review.

Authors:  Idam de Oliveira-Junior; Eliana Aguiar Petri Nahas; Ana Cristina Cherem; Jorge Nahas-Neto; René Aloisio da Costa Vieira
Journal:  Breast Care (Basel)       Date:  2020-03-27       Impact factor: 2.860

4.  Analysis of the causes of false negative and false positive results of preoperative axillary ultrasound in patients with early breast cancer - a single-centre study.

Authors:  Tomasz Nowikiewicz; Adam Nowak; Magdalena Wiśniewska; Michał Wiśniewski; Magdalena Nowikiewicz; Wojciech Zegarski
Journal:  Contemp Oncol (Pozn)       Date:  2018-12-31

5.  Nomograms for Predicting Axillary Lymph Node Status Reconciled With Preoperative Breast Ultrasound Images.

Authors:  Dongmei Liu; Yujia Lan; Lei Zhang; Tong Wu; Hao Cui; Ziyao Li; Ping Sun; Peng Tian; Jiawei Tian; Xia Li
Journal:  Front Oncol       Date:  2021-04-07       Impact factor: 6.244

6.  Comparative study of core needle biopsy and fine needle aspiration in the treatment of metastatic lymph nodes guided by contrast-enhanced ultrasound.

Authors:  Wei-Na Mu; Jian-Heng Li; Ying Liu; Hui-Qing Liang; Xin Liu
Journal:  Pak J Med Sci       Date:  2022 Jul-Aug       Impact factor: 2.340

7.  Fine needle aspiration cytology of lymph nodes in breast cancer follow-up is a feasible alternative to watchful waiting and to histology.

Authors:  Matthias Hammon; Peter Dankerl; Rolf Janka; David L Wachter; Arndt Hartmann; Rüdiger Schulz-Wendtland; Michael Uder; Evelyn Wenkel
Journal:  BMC Womens Health       Date:  2015-12-03       Impact factor: 2.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.